Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - EPS
EPS ALNY - Alnylam Pharmaceuticals, Inc.
-3.52
LAST VALUE
30.08%
2 YEAR CAGR
14.20%
5 YEAR CAGR
-9.27%
10 YEAR CAGR